D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIS
3976
DELISTED
Aris Water Solutions
ARIS
| $422K | ﹤0.01% |
33,076
-34,054
| -51% | -$582K |
|
3977
Live Nation Entertainment
LYV
$42.1B
| $422K | ﹤0.01% |
+5,551
| New | +$497K |
|
3978
Atlanta Braves Holdings Series B
BATRK
$3.27B
| $421K | ﹤0.01% |
15,320
-7,510
| -33% | -$205K |
|
3979
PUT
Baker Hughes
BKR
$58B
| $419K | ﹤0.01% |
20,000
| – | – |
|
3980
KT
KT
$8.95B
| $419K | ﹤0.01% |
34,303
-220,576
| -87% | -$3.04M |
|
3981
Adaptive Biotechnologies
ADPT
$3.6B
| $418K | ﹤0.01% |
58,684
-97,500
| -62% | -$918K |
|
|
FLNA
3982
CALL
Filana Therapeutics
FLNA
$42.7M
| $418K | ﹤0.01% |
10,000
| – | – |
|
3983
Cohu
COHU
$2B
| $417K | ﹤0.01% |
+16,172
| New | +$449K |
|
3984
Carvana
CVNA
$47.3B
| $417K | ﹤0.01% |
102,650
-1,353,450
| -93% | -$8.83M |
|
3985
Vishay Intertechnology
VSH
$5.02B
| $416K | ﹤0.01% |
23,394
-88,052
| -79% | -$1.72M |
|
3986
Vitamin Cottage Natural Grocers
NGVC
$744M
| $415K | ﹤0.01% |
38,448
-4,461
| -10% | -$66.2K |
|
3987
RLI Corp
RLI
$5.97B
| $415K | ﹤0.01% |
+8,106
| New | +$453K |
|
|
AAMI
3988
Acadian Asset Management
AAMI
$2.94B
| $415K | ﹤0.01% |
+27,838
| New | +$500K |
|
|
ZYNE
3989
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $415K | ﹤0.01% |
567,116
-542,039
| -49% | -$615K |
|
|
CAJ
3990
DELISTED
Canon, Inc.
CAJ
| $415K | ﹤0.01% |
19,041
-141,470
| -88% | -$3.33M |
|
|
PCSB
3991
DELISTED
PCSB Financial Corporation
PCSB
| $415K | ﹤0.01% |
23,160
+12,681
| +121% | +$242K |
|
3992
Alamos Gold
AGI
$12.1B
| $414K | ﹤0.01% |
55,913
-485,049
| -90% | -$3.59M |
|
|
CWAN
3993
DELISTED
Clearwater Analytics
CWAN
| $414K | ﹤0.01% |
24,657
-27,189
| -52% | -$397K |
|
3994
PUT
General Mills
GIS
$20.1B
| $414K | ﹤0.01% |
+5,400
| New | +$412K |
|
|
PFHD
3995
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $414K | ﹤0.01% |
+15,961
| New | +$407K |
|
3996
Lifecore Biomedical
LFCR
$165M
| $413K | ﹤0.01% |
46,403
-4,065
| -8% | -$41.3K |
|
|
NVEE
3997
DELISTED
NV5 Global
NVEE
| $413K | ﹤0.01% |
13,336
+936
| +8% | +$30.6K |
|
3998
Prospect Capital
PSEC
$1.12B
| $413K | ﹤0.01% |
66,544
-68,131
| -51% | -$509K |
|
|
CSR
3999
CALL
Centerspace
CSR
$941M
| $411K | ﹤0.01% |
+6,100
| New | +$484K |
|
4000
Nature's Sunshine
NATR
$365M
| $411K | ﹤0.01% |
49,930
+5,722
| +13% | +$56.8K |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.